| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/10/2001 | US6258831 Viral treatment |
| 07/10/2001 | US6258830 Skin disorders, psoriasis and acne |
| 07/10/2001 | US6258828 Chelating agents and their metal chelates for treating free radical induced conditions |
| 07/10/2001 | US6258827 Combinations for the treatment of parkinsonism containing selective NMDA antagonists |
| 07/10/2001 | US6258826 Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome |
| 07/10/2001 | US6258824 Treatment of hyperproliferative diseases, such as cancers, in mammals. this invention also relates to a pharmaceutical compositions containing such compounds. |
| 07/10/2001 | US6258821 Compositions comprising trimetrexate and methods of their synthesis and use |
| 07/10/2001 | US6258820 Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines |
| 07/10/2001 | US6258818 Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome |
| 07/10/2001 | US6258817 Substituted pyrazin-2-yl-sulphonamide (-3-pyridyl) compounds and uses thereof |
| 07/10/2001 | US6258816 Anti-allergy anti-inflammatory composition |
| 07/10/2001 | US6258815 Specific immunophilin ligands as antiasthmatics and immunosuppressants |
| 07/10/2001 | US6258814 Intranasal administering as sedatives |
| 07/10/2001 | US6258813 D4 receptor selectivity piperazine derivatives |
| 07/10/2001 | US6258812 Phthalazines with angiogenesis inhibiting activity |
| 07/10/2001 | US6258811 Methods for preventing, inhibiting or treating graft rejection reactions in graft-versus-host disease (GVHD) and organ transplantation |
| 07/10/2001 | US6258809 6-aryloxy and arylthiopurines |
| 07/10/2001 | US6258807 Neuropathic pain and analgesics |
| 07/10/2001 | US6258806 Peptides with cyclic diazaalkanes for prevention of premature metabolism method for inhibiting an hiv protease in a mammal in need of such protease inhibition, comprising administering to said mammal an effective dosage |
| 07/10/2001 | US6258804 Triazepinones, process for their preparation and their therapeutic application |
| 07/10/2001 | US6258803 11-ethyl-17-hydroxy-19-norpregn-4-en-20-yn-3-one for menopause treatment |
| 07/10/2001 | US6258802 Corticoid therapy |
| 07/10/2001 | US6258800 Prodrugs of benzofuranylethyl carbamate NK1 antagonists |
| 07/10/2001 | US6258798 Method for treatment of unstable coronary artery disease by an early revascularisation together with administration of a low molecular weight heparin |
| 07/10/2001 | US6258797 Combating infection in delivery systems |
| 07/10/2001 | US6258795 Compounds for treatment of diabetes, cardiovascular disorders, nervous system disorders and respiratory system disorders |
| 07/10/2001 | US6258794 Antidepressants and compounds that inhibit adenosine uptake |
| 07/10/2001 | US6258792 Cationic cholesteryl derivatives containing cyclic polar groups |
| 07/10/2001 | US6258791 Enhanced delivery of nucleic acid into humans or animals |
| 07/10/2001 | US6258790 Antisense modulation of integrin α4 expression |
| 07/10/2001 | US6258786 Antitumor agents of anthracycline glycosides |
| 07/10/2001 | US6258780 Method and composition for enabling passage through the blood-brain-barrier |
| 07/10/2001 | US6258775 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 07/10/2001 | US6258600 Antisense modulation of caspase 8 expression |
| 07/10/2001 | US6258584 Drug screening for modulators of collagen formation by measuring enzyme activity in presence and absence of compound; reduced activity indicates enzyme inhibitor; antiarthritic agents; antiscarring agents |
| 07/10/2001 | US6258580 Amino acid sequence of adaptor protein required for g protein-dependent activation of phosphatidylinositol-3-kinase; drug screening; diagnosis; antiarthritic agents; antiinflammatory agents; adult respiratory distress syndrome |
| 07/10/2001 | US6258578 His5 |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/10/2001 | US6258557 Nucleotide sequences associated with preferential gene expression; for the treatment of vascular injury; for reducing or preventing the development of arteriosclerosis |
| 07/10/2001 | US6258532 Evaluating sensitivity of microorganism to test substance; incubate microorganism with test substance, screen for microorganism sequences, absence of microorganismal nucleotide sequences indicates sensitivity to test substance |
| 07/10/2001 | US6258525 Method and kit for detecting infertility |
| 07/10/2001 | US6258386 Smilagenin and its use |
| 07/10/2001 | US6258381 Tablet and process for making the same |
| 07/10/2001 | US6258379 Kit with container including indicia and instructions for concurrent diuretic administration |
| 07/10/2001 | US6258376 Treating helicobacter infections and gastrointestinal disorders; antiulcer agents |
| 07/10/2001 | US6258373 Treatment of sexual dysfunction in certain patient groups |
| 07/10/2001 | US6258372 Xylitol nose spray |
| 07/10/2001 | US6258365 Organosilicone gel compositions for personal care |
| 07/10/2001 | US6258353 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 07/10/2001 | US6258341 Drug dispersion for oral inhalation and pulmonary absorption |
| 07/10/2001 | US6258032 Method of diagnosis and treatment and related compositions and apparatus |
| 07/10/2001 | US6257233 Dry powder dispersing apparatus and methods for their use |
| 07/10/2001 | CA2213241C Indole derivative for the treatment of migraine |
| 07/10/2001 | CA2175643C Utilization of retinoids in a cosmetic composition or in the preparation of a pharmaceutical composition |
| 07/10/2001 | CA2175502C Cyclic amide derivatives |
| 07/10/2001 | CA2139653C Optically pure salts of pyridinylmethyl sulfinyl-ih- benzimidazole compounds |
| 07/10/2001 | CA2069608C Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation |
| 07/10/2001 | CA2059792C Tricyclic compounds and intermediates thereof |
| 07/10/2001 | CA2040947C Platelet-aggregation inhibitors |
| 07/10/2001 | CA2017135C Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides, processes for their preparation and their use in medicaments |
| 07/06/2001 | WO2001040315A1 The alginate having low molecular weight, methods of manufacturing it and its use |
| 07/06/2001 | CA2430277A1 The alginate having low molecular weight, methods of manufacturing it and its use |
| 07/05/2001 | WO2001048483A2 Method for screening of appetite control agents |
| 07/05/2001 | WO2001048238A2 Chemotherapeutant screening method |
| 07/05/2001 | WO2001048231A2 Method of achieving persistent transgene expression |
| 07/05/2001 | WO2001048209A2 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | WO2001048190A2 Therapeutic uses of lna-modified oligonucleotides |
| 07/05/2001 | WO2001048171A1 IDENTIFICATION OF NOVEL SPLICE VARIANTS OF THE HUMAN CATALYTIC SUBUNIT Cβ OF cAMP-DEPENDENT PROTEIN KINASE AND THE USE THEREOF |
| 07/05/2001 | WO2001048170A1 A NOVEL ISOFORM OF HUMAN cAMP-DEPENDENT PROTEIN KINASE, Cα-s, LOCALIZES TO SPERM MIDPIECE AND THE USE THEREOF |
| 07/05/2001 | WO2001048163A2 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 07/05/2001 | WO2001048162A2 Method for the production of vitamin a |
| 07/05/2001 | WO2001048161A2 Human heparanase-related polypeptide and nucleic acid |
| 07/05/2001 | WO2001047960A1 Uses of transport proteins for controlling cell cycle |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047943A1 Antisense modulation of akt-3 expression |
| 07/05/2001 | WO2001047941A2 Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use |
| 07/05/2001 | WO2001047940A1 Benzophenone glycopyranosides, preparation and therapeutic use |
| 07/05/2001 | WO2001047935A2 Novel bisamidate phosphonate prodrugs |
| 07/05/2001 | WO2001047934A1 Isoxazolo pyrimidinones and the use thereof |
| 07/05/2001 | WO2001047933A1 New polymorphic forms of olanzapine |
| 07/05/2001 | WO2001047930A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 07/05/2001 | WO2001047929A1 Triazolotriazinones and the use thereof |
| 07/05/2001 | WO2001047928A2 Imidazo 1,3,5 triazinones and the use thereof |
| 07/05/2001 | WO2001047927A1 Compound and method for the treatment of pain |
| 07/05/2001 | WO2001047926A1 Compounds and methods for the treatment of pain |
| 07/05/2001 | WO2001047925A1 Compounds and methods for the treatment of pain |
| 07/05/2001 | WO2001047924A1 Methods and compositions for the treatment of pain |
| 07/05/2001 | WO2001047923A1 Compounds and methods for the treatment of pain |
| 07/05/2001 | WO2001047922A2 Azaindoles |
| 07/05/2001 | WO2001047921A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | WO2001047920A1 Benzazole derivatives and their use as jnk modulators |
| 07/05/2001 | WO2001047919A1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 07/05/2001 | WO2001047918A2 Azolyalkyl-oxa(di)azolyl pyri(mi)dine derivatives, a method for their production and their use as pesticides |
| 07/05/2001 | WO2001047916A1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 07/05/2001 | WO2001047915A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047914A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047913A2 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 07/05/2001 | WO2001047905A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047904A1 Thiazolyl amide derivatives |
| 07/05/2001 | WO2001047901A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |